Evaluation of Hepatocellular Carcinoma Treatment Response After Locoregional Therapy

Locoregional therapy (LRT) for hepatocellular carcinoma can be used alone or with other treatment modalities to reduce rates of progression, improve survival, or act as a bridge to cure. As the use of LRT expands, so too has the need for systems to evaluate treatment response, such as the World Health Organization and modified Response Evaluation Criteria In Solid Tumors systems and more recently, the Liver Imaging Reporting and Data System (LI-RADS) treatment response algorithm (TRA). Early validation results for LI-RADS TRA have been promising, and as research accrues, the TRA is expected to evolve in the near future.

Source: Magnetic Resonance Imaging Clinics of North America - July 7, 2021 Category: Radiology Authors: Rony Kampalath, Karen Tran-Harding, Richard K.G. Do, Mishal Mendiratta-Lala, Vahid Yaghmai Source Type: research